Free Trial

PharVision Advisers LLC Buys New Shares in Ambarella, Inc. $AMBA

Ambarella logo with Computer and Technology background

Key Points

  • PharVision Advisers LLC has acquired a new stake in Ambarella, Inc., purchasing 5,335 shares valued at approximately $269,000, highlighting growing institutional interest in the company.
  • Equities analysts have raised their price targets for Ambarella, with Bank of America increasing its target from $63 to $90 and Morgan Stanley raising it from $80 to $96, indicating strong market confidence in the company's performance.
  • Ambarella's recent earnings exceeded expectations with a reported EPS of $0.15, surpassing the consensus estimate by $0.10, and the company's revenue increased by 49.9% year-over-year.
  • Five stocks we like better than Ambarella.

PharVision Advisers LLC purchased a new stake in shares of Ambarella, Inc. (NASDAQ:AMBA - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 5,335 shares of the semiconductor company's stock, valued at approximately $269,000.

Several other institutional investors and hedge funds also recently made changes to their positions in AMBA. Nuveen LLC bought a new stake in shares of Ambarella during the first quarter valued at approximately $32,169,000. Jacobs Levy Equity Management Inc. increased its position in shares of Ambarella by 1,635.4% during the first quarter. Jacobs Levy Equity Management Inc. now owns 647,788 shares of the semiconductor company's stock valued at $32,603,000 after acquiring an additional 610,460 shares in the last quarter. Segall Bryant & Hamill LLC bought a new stake in shares of Ambarella during the first quarter valued at approximately $15,578,000. Woodline Partners LP increased its position in shares of Ambarella by 2,367.1% during the fourth quarter. Woodline Partners LP now owns 263,333 shares of the semiconductor company's stock valued at $19,155,000 after acquiring an additional 252,659 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. increased its position in shares of Ambarella by 25.6% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 910,911 shares of the semiconductor company's stock valued at $45,846,000 after acquiring an additional 185,444 shares in the last quarter. Institutional investors own 82.09% of the company's stock.

Insider Activity

In other news, Director Christopher B. Paisley sold 1,000 shares of the business's stock in a transaction on Wednesday, June 25th. The shares were sold at an average price of $62.58, for a total transaction of $62,580.00. Following the completion of the sale, the director owned 39,281 shares of the company's stock, valued at $2,458,204.98. The trade was a 2.48% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 5.30% of the stock is currently owned by insiders.

Ambarella Stock Performance

Shares of AMBA stock traded down $2.51 during mid-day trading on Friday, reaching $80.63. 131,682 shares of the company's stock traded hands, compared to its average volume of 871,527. Ambarella, Inc. has a 12 month low of $38.86 and a 12 month high of $93.44. The firm has a 50 day moving average price of $70.42 and a two-hundred day moving average price of $59.67. The firm has a market capitalization of $3.44 billion, a PE ratio of -38.20 and a beta of 2.09.

Ambarella (NASDAQ:AMBA - Get Free Report) last issued its quarterly earnings data on Thursday, August 28th. The semiconductor company reported $0.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.05 by $0.10. Ambarella had a negative net margin of 25.46% and a negative return on equity of 14.73%. The firm had revenue of $95.51 million during the quarter, compared to the consensus estimate of $90.01 million. During the same quarter in the previous year, the firm posted ($0.13) EPS. The company's revenue for the quarter was up 49.9% compared to the same quarter last year. Ambarella has set its Q3 2026 guidance at EPS. As a group, equities analysts expect that Ambarella, Inc. will post -2.81 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have commented on AMBA shares. BNP Paribas raised shares of Ambarella to a "strong-buy" rating in a research report on Friday, August 29th. Northland Securities lifted their target price on shares of Ambarella from $75.00 to $95.00 and gave the stock an "outperform" rating in a research report on Friday, August 29th. Summit Insights raised shares of Ambarella from a "hold" rating to a "buy" rating in a research report on Friday, August 29th. Susquehanna lifted their target price on shares of Ambarella from $80.00 to $90.00 and gave the stock a "positive" rating in a research report on Tuesday, July 22nd. Finally, Roth Capital reaffirmed a "neutral" rating on shares of Ambarella in a research report on Friday, August 29th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Ambarella currently has a consensus rating of "Moderate Buy" and a consensus price target of $93.88.

View Our Latest Stock Analysis on AMBA

Ambarella Profile

(Free Report)

Ambarella, Inc develops semiconductor solutions that enable high-definition (HD) and ultra HD compression, image signal processing, and artificial intelligence processing worldwide. The company's system-on-a-chip designs integrated HD video processing, image processing, artificial intelligence computer vision algorithms, audio processing, and system functions onto a single chip for delivering video and image quality, differentiated functionality, and low power consumption.

Featured Stories

Institutional Ownership by Quarter for Ambarella (NASDAQ:AMBA)

Should You Invest $1,000 in Ambarella Right Now?

Before you consider Ambarella, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambarella wasn't on the list.

While Ambarella currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The AI-Proof Portfolio: 3 Stocks You Need to See
Markets Brace for Fed: What Investors Need to Know Before Wednesday
3 Biotech Stocks Under $5 With Huge Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines